Advertisement
Brief report| Volume 20, ISSUE 2, P205-208, February 1985

Download started.

Ok

A placebo-controlled trial of valproate in tardive dyskinesia

  • Henry A. Nasrallah
    Correspondence
    Address reprint requests to: Henry A. Nasranah, M.D., Psychiatry Service, V.A. Medical Center, Iowa City, Iowa 52240 USA
    Footnotes
    Affiliations
    From the Veterans Administration Medical Center and the Department of Psychiatry, University of Iowa College of Medicine, Iowa City, Iowa 52240, USA
    Search for articles by this author
  • Frederick J. Dunner
    Footnotes
    Affiliations
    From the Veterans Administration Medical Center and the Department of Psychiatry, University of Iowa College of Medicine, Iowa City, Iowa 52240, USA
    Search for articles by this author
  • Mona McCalley-Whitters
    Footnotes
    Affiliations
    From the Veterans Administration Medical Center and the Department of Psychiatry, University of Iowa College of Medicine, Iowa City, Iowa 52240, USA
    Search for articles by this author
  • Author Footnotes
    1 We acknowledge the valuable cooperation of the nursing staff at the V.A. Medical Center, Psychiatry Service, and the Clinical Research Center at the University of Iowa (Barry Sherman, M.D. Director).
DOI:https://doi.org/10.1016/0006-3223(85)90084-8
A placebo-controlled trial of valproate in tardive dyskinesia
Previous ArticleLithium in prophylactic therapy of manic-depressive illness: Biochemical correlates of response
Next ArticleEffect of valproic acid on behavior and plasma amino acid concentrations in chronic schizophrenic patients
      This paper is only available as a PDF. To read, Please Download here.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Biological Psychiatry
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Register: Create an account
      Institutional Access: Sign in to ScienceDirect

      References

        • Casey D.E.
        • Hammerstad J.P.
        Sodium valproate in tardive dyskinesia.
        J Clin Psychiatry. 1970; 40: 483-485
        • Chien C.P.
        • Jung K.
        • Ross-Townsend A.
        Efficacies of agents related to GABA, dopamine and acetylcholine in the treatment of tardive dyskinesia.
        Psychopharmacol Bull. 1978; 14: 20-22
        • Gibson A.C.
        Sodium valproate and tardive dyskinesia.
        Br J Psychiatry. 1978; 133: 82
        • Godin Y.
        • Heiner L.
        • Mark J.
        • et al.
        Effects of di-n-propylacetate, an anticonvulsant compound, on GABA metabolism.
        J Neurochem. 1969; 16: 867-873
        • Jeste D.V.
        • Wyatt R.J.
        Changing epidemiology of tardive dyskinesia.
        Am J Psychiatry. 1981; 138: 297-309
        • Jeste D.V.
        • Wyatt R.J.
        Therapeutic strategies against tardive dyskinesia. Two decades of experience.
        Arch Gen Psychiatry. 1982; 39: 803-816
        • Linnoila M.
        • Viukkari M.
        • Hietala O.
        Effect of sodium valproate on tardive dyskinesia.
        Br J Psychiatry. 1976; 129: 114-119
        • Nasrallah H.A.
        Methodological issues in tardive dyskinesia research.
        Schiz Bull. 1979; 5: 1-3
        • Price P.A.
        • Parkes J.D.
        • Marsden C.D.
        Sodium valproate in the treatment of levodopa-induced dyskinesia.
        J Neurol Neurosurg Psychiatry. 1978; 41: 702-706
        • Schooler N.R.
        • Kane J.M.
        Research diagnoses for tardive dyskinesia.
        Arch Gen Psychiatry. 1982; 39: 486-487
        • Shoulson K.
        • Kartzinel R.
        • Chase T.N.
        Huntington's disease: Treatment with dipropylacetic acid and gamma-amino-butyric acid.
        Neurology. 1976; 26: 61-63
        • Singh M.M.
        • Becker R.E.
        • Pitman R.K.
        • et al.
        Diazepam-induced changes in tardive dyskinesia.
        Biol Psychiatry. 1982; 17: 729-742
        • Tamminga C.A.
        • Crayton J.W.
        • Chase T.N.
        Improvement in tardive dyskinesia after muscimol therapy.
        Arch Gen Psychiatry. 1979; 36: 595-598

      Article info

      Publication history

      Received in revised form: August 20, 1984
      Received: May 3, 1984

      Footnotes

      ☆Supported by the Veterans Administration Merit Review Program and National Institutes of Health grant RR59 GCRC.

      Identification

      DOI: https://doi.org/10.1016/0006-3223(85)90084-8

      Copyright

      © 1985 Published by Elsevier Inc.

      ScienceDirect

      Access this article on ScienceDirect

      The content on this site is intended for healthcare professionals.


      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the Cookie Preference Center for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties.


      RELX